Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
4
×
boston top stories
life sciences
national blog main
biotech
fda
national top stories
alexion pharmaceuticals
boston
boulder/denver blog main
boulder/denver top stories
clinical trials
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
medicare
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
ucb
wisconsin blog main
wisconsin top stories
abbvie
adalimumab
administration
albert bourla
alex azar
alliance for aging research
What
drug
4
×
pharma
4
×
disease
medicines
pharmaceuticals
administration
alternative
angry
anti
autoimmune
away
benefited
bringing
candidate
caught
causing
ceos
dc
deal
despite
dicerna
executives
expensive
eye
fear
gathered
gene
groups
hearing
held
hepatitis
industry
intended
lead
losing
lower
pay
pharmaceutical
plans
potential
Language
unset
Current search:
pharma
×
drug
×
" boston blog main "
×
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
